BPI Theater @ BIO 2022

Featured on BPI Theater @ BIO 2022

BioProcess Insider Interview: Dr. Ger Brophy, Avantor
Sponsored Content
BioProcess Insider Interview: Dr. Ger Brophy, AvantorBioProcess Insider Interview: Dr. Ger Brophy, Avantor

byBPI Contributor
Sep 1, 2022
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
Sponsored Content
How Our Partnerships Move Your Life-Changing Biologics to Market: Two Case StudiesHow Our Partnerships Move Your Life-Changing Biologics to Market: Two Case Studies
byBPI Staff
Aug 26, 2022
BioProcess Insider Interview: Tom VanCott, Catalent
Sponsored Content
BioProcess Insider Interview: Tom VanCott, CatalentBioProcess Insider Interview: Tom VanCott, Catalent
byBPI Contributor
Aug 24, 2022
BioProcess Insider Interview: Dave Backer, Oxford Biomedica
Sponsored Content
BioProcess Insider Interview: Dave Backer, Oxford BiomedicaBioProcess Insider Interview: Dave Backer, Oxford Biomedica
byBPI Contributor
Aug 24, 2022
BioProcess Insider Interview: Greg Bleck, Catalent
Sponsored Content
BioProcess Insider Interview: Greg Bleck, CatalentBioProcess Insider Interview: Greg Bleck, Catalent
byBPI Contributor
Aug 24, 2022
BioProcess Insider Interview: Brian Finrow, Lumen Biosciences
Sponsored Content
BioProcess Insider Interview: Brian Finrow, Lumen BiosciencesBioProcess Insider Interview: Brian Finrow, Lumen Biosciences
byBPI Contributor
Aug 24, 2022

More from BPI Theater @ BIO 2022

BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
Sponsored Content
BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
BioProcess Insider Interview: Jon Gunther, Just-Evotec Biologics
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
Sponsored Content
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
BioProcess Insider Interview: Emmanuel Ligner, Cytiva
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
Sponsored Content
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
BioProcess Insider Interview: Claudia Melara, Gamma Biosciences
Aug 24, 2022
byBPI Contributor
BioProcess Insider Interview: James Park, Samsung Biologics
Sponsored Content
BioProcess Insider Interview: James Park, Samsung Biologics
BioProcess Insider Interview: James Park, Samsung Biologics
Aug 24, 2022
byBPI Contributor
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Sponsored Content
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Cell and Gene Therapy Modalities: Business and Manufacturing Strategies Influencing the Decision to Develop One Therapy Type Instead of Another
Aug 24, 2022
byBPI Contributor
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Sponsored Content
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Cell and Gene Therapy: Introducing New Technologies to Compress Timelines, Increase Capacity, and Reduce Risk
Aug 24, 2022
byBPI Contributor
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Sponsored Content
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Platform Processes Accelerating AAV Vector Production from Gene to Clinic
Aug 24, 2022
byBPI Contributor
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Sponsored Content
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Building a Comprehensive Toolbox for Oligonucleotide Drug Discovery
Aug 24, 2022
byBPI Contributor
The Future of AAV Gene Therapy Is Scalable
Sponsored Content
The Future of AAV Gene Therapy Is Scalable
The Future of AAV Gene Therapy Is Scalable
Aug 24, 2022
byBPI Contributor
Enabling Next-Generation Biomanufacturing Using Cell-Free Technology
Sponsored Content
Enabling Next-Generation Biomanufacturing Using Cell-Free Technology
Enabling Next-Generation Biomanufacturing Using Cell-Free Technology
Aug 24, 2022
byBPI Contributor
Innovation as the Key to Gene Therapy Manufacturing
Sponsored Content
Innovation as the Key to Gene Therapy Manufacturing
Innovation as the Key to Gene Therapy Manufacturing
Aug 24, 2022
byBPI Contributor
How a Robust, Fully Integrated, and Highly Vetted Cell-Line Development Platform Accelerates IND Timelines
Sponsored Content
How a Robust, Fully Integrated, and Highly Vetted Cell-Line Development Platform Accelerates IND Timelines
How a Robust, Fully Integrated, and Highly Vetted Cell-Line Development Platform Accelerates IND Timelines
Aug 24, 2022
byBPI Contributor
Accelerating Industrialization of Genomic Medicine
Sponsored Content
Accelerating Industrialization of Genomic Medicine
Accelerating Industrialization of Genomic Medicine
Aug 24, 2022
byBPI Contributor
Partnering with a CDMO: Past the Service Offering
Sponsored Content
Partnering with a CDMO: Past the Service Offering
Partnering with a CDMO: Past the Service Offering
Aug 24, 2022
byBPI Contributor
Overcome Costly Hit-Finding Challenges Using an Integrated Platform
Sponsored Content
Overcome Costly Hit-Finding Challenges Using an Integrated Platform
Overcome Costly Hit-Finding Challenges Using an Integrated Platform
Aug 24, 2022
byBPI Contributor
How a Premier, Single-Source Platform Accelerates Biologic Drug Discovery and Innovation
Sponsored Content
How a Premier, Single-Source Platform Accelerates Biologic Drug Discovery and Innovation
How a Premier, Single-Source Platform Accelerates Biologic Drug Discovery and Innovation
Aug 24, 2022
byBPI Contributor
Roundtable Discussion — Recombinant Protein Manufacturing: Lessons to Be Taken from the Emerging Cell and Gene Therapy Space
Sponsored Content
Roundtable Discussion — Recombinant Protein Manufacturing: Lessons to Be Taken from the Emerging Cell and Gene Therapy Space
Roundtable Discussion — Recombinant Protein Manufacturing: Lessons to Be Taken from the Emerging Cell and Gene Therapy Space
Aug 24, 2022
byBPI Contributor
Shortening Clinical Development Timelines Using Novel Technology for Generating Stable, High-Producing Cell Pools and Cell Lines
Sponsored Content
Shortening Clinical Development Timelines Using Novel Technology for Generating Stable, High-Producing Cell Pools and Cell Lines
Shortening Clinical Development Timelines Using Novel Technology for Generating Stable, High-Producing Cell Pools and Cell Lines
Aug 24, 2022
byBPI Contributor
Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic
Sponsored Content
Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic
Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic
Aug 24, 2022
byBPI Contributor
Improvements and Innovations in Lentiviral Manufacture
Sponsored Content
Improvements and Innovations in Lentiviral Manufacture
Improvements and Innovations in Lentiviral Manufacture
Aug 24, 2022
byBPI Contributor
Advancing Biomanufacturing Capabilities with a Next-Generation Single-Use Solution
Sponsored Content
Advancing Biomanufacturing Capabilities with a Next-Generation Single-Use Solution
Advancing Biomanufacturing Capabilities with a Next-Generation Single-Use Solution
Aug 24, 2022
byBPI Contributor
Using Innovation and Investments to Advance Nanoparticle Formulations
Sponsored Content
Using Innovation and Investments to Advance Nanoparticle Formulations
Using Innovation and Investments to Advance Nanoparticle Formulations
Aug 24, 2022
byBPI Contributor
Crossing the Finish Line: Preparing for and Passing a Preapproval Inspection
Sponsored Content
Crossing the Finish Line: Preparing for and Passing a Preapproval Inspection
Crossing the Finish Line: Preparing for and Passing a Preapproval Inspection
Aug 24, 2022
byBPI Staff
The Changing CDMO Landscape
Contract Services
The Changing CDMO Landscape
The Changing CDMO Landscape
Aug 16, 2022
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024

LumaCyte LFC™
Sponsored Content
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™

Oct 14, 2024

ValGenesis CSV to CSA
Sponsored Content
The Shift from CSV to CSA
The Shift from CSV to CSA

Oct 14, 2024